Reference opioid. Oral:SC/IV ratio = 2:1.
Poor metabolisers (~7-10% Caucasians) get minimal analgesia
Ultra-rapid metabolisers at risk of toxicity
Risk of serotonin syndrome with SSRIs/SNRIs
Lowers seizure threshold
Conversion ratio is an estimate; noradrenergic component not captured by OME
Conversion ratio is debated (FPM vs BNF)
Not suitable for acute/unstable pain
Takes 12-24h to reach steady state after application
Partial agonist - conversion unreliable above 120mg/24h oral morphine equivalent
Specialist advice recommended for high doses
NEVER use a fixed conversion ratio
Always requires specialist palliative care or pain medicine input
Risk of accumulation and delayed respiratory depression
When switching opioids: reduce calculated dose by 25-50% for incomplete cross-tolerance. Titrate with breakthrough medication.